TSO3 Inc. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
9,270.20
5,948.00
8,106.10
5,801.80
9,675.40
17,166.20
Depreciation, Depletion & Amortization
791.70
662.70
520.70
593.60
1,253.90
1,441.30
Other Funds
7.20
433.10
829.00
1,363.30
2,988.00
570.30
Funds from Operations
8,471.30
4,852.20
6,756.40
3,700.50
5,552.90
15,110.50
Changes in Working Capital
517.20
1,061.50
10,054.60
3,440.80
1,490.10
12,611.50
Net Operating Cash Flow
8,988.40
3,790.70
3,298.20
7,141.30
4,062.80
27,722
Capital Expenditures
500.30
200.80
577.00
1,853.60
2,346.80
Sale of Fixed Assets & Businesses
-
-
-
-
2.60
Purchase/Sale of Investments
2,069.00
2,961.80
3,399.30
18,590.00
12,645.20
Net Investing Cash Flow
1,568.70
2,761.00
3,976.30
20,443.50
10,301.00
Net Financing Cash Flow
6,299.10
365.80
11,712.70
14,394.00
700.90
Net Change in Cash
1,120.70
664.00
9,601.70
13,190.90
6,939.20
Free Cash Flow
9,189.80
3,814.20
3,052.60
8,578.90
6,099.40
Deferred Taxes & Investment Tax Credit
-
-
-
144.40
119.40
44.10
Change in Capital Stock
6,299.10
365.80
11,712.70
14,394.00
700.90
Exchange Rate Effect
-
-
1,432.90
-
-

About TSO3

View Profile
Address
2505, avenue Dalton
Québec Québec G1P 3S5
Canada
Employees -
Website http://www.tso3.com
Updated 07/08/2019
TSO3, Inc. engages in the business of medical devices. Its activities include manufacturing, sale; research and development, licensing of sterilization processes, related consumable supplies, and accessories for medical devices that are sensitive to heat and moisture. It operates through the Canada and Worldwide; and United States geographical segments.